Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62.7M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
+18.9M
-
Total reported value, excl. options
-
$595M
-
Value change
-
+$595M
-
Number of buys
-
50
-
Price
-
$31.50
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2014
50 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q3 2014.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 62.7M outstanding shares and own 30.16% of the company stock.
Largest 10 shareholders include Third Rock Ventures, LLC (11.7M shares), FMR LLC (3.86M shares), ORBIMED ADVISORS LLC (537K shares), DEERFIELD MANAGEMENT CO (451K shares), RS INVESTMENT MANAGEMENT CO LLC (289K shares), ALLIANCEBERNSTEIN L.P. (255K shares), PERCEPTIVE ADVISORS LLC (209K shares), FEDERATED INVESTORS INC /PA/ (204K shares), FRANKLIN RESOURCES INC (200K shares), and BlackRock Fund Advisors (142K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.